Okta Poised to Surge Over 20%? Top 10 Wall Street Analysts' Latest Forecasts

Top Wall Street analysts have changed their views on these popular stocks. For all analyst rating changes, see our analyst ratings page.

Keefe, Bruyette & Woods raised its price target on Progressive Corp from $226 to $250. Keefe, Bruyette & Woods analyst Meyer Shields upgraded the stock from Market Perform to Outperform. Progressive shares closed Wednesday at $217.27. See how other analysts view the stock.

Cantor Fitzgerald raised its price target on Ultragenyx Pharmaceutical Inc from $96 to $103. Cantor Fitzgerald analyst Kristen Kluska maintained an Overweight rating. Ultragenyx Pharmaceutical shares closed Wednesday at $26.24. See how other analysts view the stock.

Ascendiant Capital lowered its price target on Travelzoo from $23 to $20. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Travelzoo shares closed Wednesday at $6.88. See how other analysts view the stock.

Needham raised its price target on Analog Devices Inc from $440 to $450. Needham analyst N. Quinn Bolton maintained a Buy rating. Analog Devices shares closed Wednesday at $373.26. See how other analysts view the stock.

Morgan Stanley raised its price target on Merck & Co Inc from $116 to $179. Morgan Stanley analyst Terence Flynn upgraded the stock from Equal Weight to Overweight. Merck shares closed Wednesday at $152.20. See how other analysts view the stock.

BTIG raised its price target on Glaukos Corp from $193 to $202. BTIG analyst Ryan Zimmerman maintained a Buy rating. Glaukos shares closed Wednesday at $189.55. See how other analysts view the stock.

Morgan Stanley raised its price target on Moderna Inc from $39 to $89. Morgan Stanley analyst Terence Flynn maintained an Equal Weight rating. Moderna shares closed Wednesday at $174.38. See how other analysts view the stock.

Needham raised its price target on NIQ Global Intelligence PLC from $18 to $21. Needham analyst Kyle Peterson maintained a Buy rating. NIQ Global Intelligence shares closed Wednesday at $18.31. See how other analysts view the stock.

Cantor Fitzgerald raised its price target on Okta Inc from $125 to $170. Cantor Fitzgerald analyst Jonathan Ruykhaver maintained an Overweight rating. Okta shares closed Wednesday at $141.21. See how other analysts view the stock.

Cantor Fitzgerald raised its price target on Rubrik Inc from $95 to $120. Cantor Fitzgerald analyst Jonathan Ruykhaver maintained an Overweight rating. Rubrik shares closed Wednesday at $99.78. See how other analysts view the stock.

Considering buying OKTA stock? Here's what analysts think.